Alasan Memilih Produk IMMUNOCAL

BERIKUT ADALAH PRESS RELEASE MANFAAT IMMUNOCAL TERHADAP AUTIS

Haid Yang Sangat Menyiksa

Varisesku Hilang, Betis Mulus Kembali

Kanker Payudara

Alergi dan Maag Tidak Lagi Mengganggu

Tubuh Sehat Dengan Immunocal

Berkat Immunocal Paru-paru Mita Disembuhkan

Terbebas dari KANKER PAYUDARA Stadium 3

Jantung Anakku Kembali Normal

Brosur Immunocal Platinum

Brosur Immunocal

Proses Pembuatan Immunocal

Proses ini telah di patent kan dan hanya Immunotec Inc. yang memiliki teknologi tersebut.
Jelasnya silahkan klik pada gambar.

Glutathione (GSH) dan Peranannya pada Diabetes

Liputan Seminar Kesehatan tentang peranan Glutathione pada penderita DM. Klik gambar untuk memperjelas.

IMMUNOCAL & KANKER, Dapatkah disembuhkan?

Silahkan klik gambar artikel di bawah ini untuk lebih jelasnya.

Perbedaan Immunocal & Colostrum

PATENTS

Immunocal
70 International "Method of Use" Patents.

Before we look at the actual patents that have been registered for Immunocal, it is critically important to recognize a few factors that set our product apart from ANY OTHER NEUTRACEUTICAL on the market. You can see that we make specific reference to the fact that the Immunocal Patents are "METHOD OF USE" Patents. Since most of the population knows what a "PATENT" is, this does not have to be explained. However, most of the population DOES NOT KNOW what a "Method of Use" Patent is. So, here is the difference; Just about anything can be patented by anyone, for things like; a new invention, a new way to manufacture something or a new blend of ingredients, all for a particular product that someone has created. These are very good patents for protecting something, so that it cannot be legally reproduced by someone else. "Method of Use" Patents on the other hand are normally restricted to drugs because they actually state a specific result which has been proven scientifically, with Medical Community Standards of Research needed before they can be registered. This is what sets Immunotec Research and Immunocal apart from the rest of the products and companies. This is what allows you to rest assured that you are consuming the BEST PRODUCT available for YOUR IMMUNE SYSTEM, guaranteeing YOU that by consuming Immunocal, you are increasing your critical intracellular glutathione.
North & South America Argentina Canada Chile Mexico United States Europe to Africa Austria Czech Republic Denmark Europe Germany Israel Italy Norway South Africa Spain Sweden United Kingdom Asia - Australia & New Zealand Australia China Japan New Zealand Singapore South Korea Taiwan
Please CLICK the country flag above to view our Patents Note: the original patents and research were done in Canada and the USA. You will notice some countries have patented all, while others have chosen to be conservative and only patent either the; Anti-cancer, HIV treatment or Immune Response patents, with the exception of Singapore. More patents will come, we are just getting started internationally...
Immunotec Inc. congratulates Dr. Luc Montagnier for winning the 2008 Nobel Prize in Medicine for his 1984 discovery, with Françoise Barré–Sinoussi, of the Human Immunodeficiency Virus (HIV). Drs. Montagnier and Barré-Sinoussi first understood that HIV “impaired the immune system because of massive virus replication and cell damage to lymphocytes.” Their seminal work set the stage for understanding the biology of the disease and current modalities of treatment. In addition, it led to development of methods of diagnosis and blood screening that has mitigated the spread of the disease. Dr. Montagnier and his colleagues edited Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper co-authored by Immunotec founding scientist Dr. Gustavo Bounous, entitled; Nutriceutical Modulation of Glutathione with a Humanized Native Milk Serum Protein Isolate, Immunocal: Application in AIDS and Cancer, Click here to View Document source : http://immunocal.md/immunocal.patents.html